Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

Add To Watchlist

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Serology tests developments?

View:

Post by Speyeder999 on Jul 16, 2021 7:34am

Serology tests developments?

As we patiently wait for news regarding their serology test , I asked myself the following question: How could they have forecasted revenue in the last quarter of last year or 1st or second of this year for that matter AND announce steps to initiate commercialization if they have yet to submit it for approval to HC or the FDA? Wouldn't it appear somewhere if it was submitted and on a waiting list? Does someone know the process involved for approval? Understanding it will make the wait a little more bearable :-)

166